Endothelin-I production and agonist activities in cultured prostate- derived cells: Implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia

Prostate

Volumn 34, Issue 4, 1998, Pages 241-250

  Walden, Paul D ^a   Ittmann, Michael ^a,b   Monaco, Marie E ^a,b   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Endothelin 1; G protein coupled receptors; Prostatic hyperplasia

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN-CONVERTING ENZYME 1; METALLOPROTEINASE;

APOPTOSIS; ARTICLE; BINDING COMPETITION; BIOAVAILABILITY; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE CONTRACTION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; PROSTATE;

APOPTOSIS; ASPARTIC ENDOPEPTIDASES; BIOLOGICAL AVAILABILITY; ENDOTHELIN-1; ENDOTHELIN-3; HUMANS; MALE; METALLOENDOPEPTIDASES; PROSTATE; PROSTATIC HYPERPLASIA; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; TUMOR CELLS, CULTURED;

EID: 0031594508     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980301)34:4<241::AID-PROS1>3.0.CO;2-K     Document Type: Article

References (46)

1. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
3. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408-C415.
4. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T: A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 1989;264:7856-7861.
5. Vigne P, Marsault R, Breittmayer JP, Frelin C: Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J 1990;266:415-420.
6. Sokolovsky M: Endothelins and sarafotoxins: Physiological regulation, receptor subtypes and transmembrane signaling. Trends Biochem Sci 1991;16:261-264.
7. Kramer BK, Nishida M, Kelly RA, Smith TW: Endothelins: Myocardial actions of a new class of cytokines. Circulation 1992;85: 350-356.
8. Bogoyevitch MA, Parker PJ, Sugden PH: Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-e is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 1993;72: 757-767.
9. Simonson MS, Dunn MJ: Cellular signaling by peptides of the endothelin gene family. FASEB J 1990;4:2989-3000.
10. Simonson MS, Herman WH: Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J Biol Chem 1993;268:9347-9357.
11. van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM, Lefkowitz RJ: Receptor-tyrosine-kinase and Gbg-mediated MAP kinase activation by a common signaling pathway. Nature 1995;376:781-784.
12. Walsh PC: Benign prostatic hyperplasia. In Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds): "Cambell's Urology," Vol 6. New York: WB Saunders, 1992, pp 1009-1027.
13. Berry SJ, Coffey DS, Walsh PC, Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-179.
14. Bartsch G, Muller HR, Oberholzer M, Rohr HP: Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979;122:487-491.
15. Shapiro E, Becich MJ, Hartanto V, Lepor H: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 1992;147:1293-1297.
16. Casey ML, Byrd W, MacDonald PC: Massive amounts of immunoreactive endothelin in human seminal fluid. J Clin Endocrinol Metab 1992;74:223-225.
17. Hartter E, Woloszczuk W: Radioimmunoassay of endothelin. Lancet 1989;1:909.
18. Saito Y, Nakao K, Itoh H, Yamada T, Mukoyama M, Arai H, Hosoda K, Shirakami G, Shin-Ichi S, Jougasaki M, Morichika S, Imura H: Endothelin in human plasma and culture medium or aortic endothelial cells-detection and characterization with radioimmune assay using monoclonal antibody. Biochem Biophys Res Commun 1989;161:320-326.
19. Langenstroer P, Tang R, Shapiro E, Divish B, Opgenorth T, Lepor H: Endothelin-1 in the human prostate: Tissue levels, source of production and isometric tension studies. J Urol 1993; 150:495-499.
20. Kobayashi S, Tang R, Wang B, Opgenorth T, Langenstroer P, Shapiro E, Lepor H: Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol Pharmacol 1994;45:306-311.
21. Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Tang R, Lepor H, Hartig PR, Weinshank RL, Branchek TA, Gluchowski C: The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Mol Pharmacol 1994;45: 703-708.
22. Webb ML, Chao CC, Rizzo M, Shapiro RA, Neubauer M, Liu EC, Aversa CR, Brittain RJ, Treiger B: Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction. Mol Pharmacol 1995;47:730-737.
23. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3109.
24. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-672.
25. Koreh K, Monaco ME: The relationship of hormone-sensitive and hormone-insensitive phosphatidylinositol to phosphatidylinositol 4,5-bisphosphate in the WRK-1 cell. J Biol Chem 1986;261:88-91.
26. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
28. Seidah NG, Day R, Marcinkiewicz M, Chretien M: Mammalian paired basic amino acid convertases of prohormones and proproteins. Ann NY Acad Sci 1993;680:135-146.
29. Kimura S, Kasuya Y, Sawamura T, Shinimi O, Sugita Y, Yanagisawa M, Goto K, Masaki T: Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity. Structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 1989;13(suppl 5):S5-S7.
30. Opgenorth TJ, Wu-Wong JR, Shiosaki K: Endothelin-converting enzymes. FASEB J 1992;6:2653-2659.
31. Kobayashi S, Tang R, Wang B, Opgenorth T, Stein E, Shapiro E, Lepor H: Localization of endothelin receptors in the human prostate. J Urol 1994;151:763-766.
32. Coffey DS, Walsh PC: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990;17:461-475.
33. Douglas WH, Terracio L, Glass H: Isolation, culture and characterization of epithelial cells derived from rat ventral prostate. Anat Rec 1980;197:239-256.
34. Kachar B, Reese TS: Formation of misplaced and reflexive tight junction strands in prostate epithelial cells. J Ultrastruct Res 1983;82:90-95.
35. Kachar B, Pinto de Silva P: Freeze-fracture study of rat ventral prostate: The columnar epithelial cell. Am J Anat 1981;161:49-69.
36. Terracio L, Douglas WH, Pennachio D, Vena RL, Ofner P: Primary epithelial cell cultures derived from canine prostate: Isolation, culture, and characterization. Am J Anat 1982;164:311-332.
37. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267: 16066-11608.
38. Yang Y, Chisholm GD, Habib FK: The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate. Prostate 1992;21:201-228.
39. Sawamura T, Shinmi O, Kishi N, Sugita Y, Yanagisawa M, Goto K, Masaki T, Kimura S: Analysis of big endothelin-1 digestion by cathepsin D. Biochem Biophys Res Commun 1990;172:883-889.
40. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y: Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994;25:91-96.
41. Engle MJ, Grove ML, Becich MJ, Mahmood A, Alpers DH: Appearance of surfactant-like particles in apical medium of Caco-2 cells may occur via tight junctions. Am J Physiol 1995;268: C1401-C1432.
42. Marmorstein AD, Mortell KH, Ratcliffe DR, Cramer EB: Epithelial permeability factor: A serum protein that condenses actin and opens tight junctions. Am J Physiol 1992;262:C1403-C1410.
43. McRoberts JA, Aranda R, Riley N, Kang H: Insulin regulates the paracellular permeability of cultured intestinal epithelial cell monolayers. J Clin Invest 1990;85:1127-1134.
44. Merk FB, Leav I, Kwan PW, Ofner P: Effects of estrogen and androgen on the ultrastructure of secretory granules and intercellular junctions in regressed canine prostate. Anat Rec 1980; 197:111-132.
45. Wendel EF, Brannen GE, Putong PB, Grayhack JT: The effect of orchiectomy and estrogens of benign prostatic hyperplasia. J Urol 1972;108:116-119.
46. Uke E, Lee C, Grayhack JT: The effect of CIS hydroxyproline on ventral prostatic growth in rats. J Urol 1983;129:171-174.